SLC36A4

Across TCGA pan-cancer cohorts, SLC36A4 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated SLC36A4 data layer compared with 24 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher SLC36A4 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated SLC36A4 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC, ACC, and HNSC are the cancer types where SLC36A4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.964	0.624	.011	32	view →
ACC	OS	Median	All	0.124	0.706	<.001	24	view →
HNSC	OS	Median	III,IV	0.152	0.746	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

SLC36A4–UCEC (DFS)

Open the UCEC breakdown →